By Mike Baker
SEATTLE: In a county north of Seattle, two people who came down with respiratory illnesses in December now have antibodies for the coronavirus. In Florida, a public health official who got sick in January believes he had COVID-19.
And in California, a surprising discovery that an early-February death in San Jose was linked to the coronavirus has triggered a broader search for how that person was exposed.
Those cases have contributed to growing questions about when the virus first reached the United States and how long it had been circulating by the time its arrival was publicly confirmed in Washington state at the end of February.
While there was limited testing to uncover specific cases before then, researchers have other tools to trace the path of the coronavirus. That includes genomic sequencing of the virus to help scientists build an ancestral tree of cases, a re-examination of specific deaths, and thousands of old flu samples that have been repurposed to look for coronavirus.
Heres a look at the evidence and what it shows:
Q: I got really sick in February. Did I have coronavirus?
A: Its possible, but it was most likely something else.
The Seattle area emerged as an early epicenter of the coronavirus outbreak at the end of February, but there is compelling evidence that, even there, the virus didnt yet have much of a foothold compared to the flu, which had a particularly potent season.
A team that analyzes flu trends in the region has been able to review nearly 7,000 old flu samples collected from around the region in January and February, re-examining them for coronavirus. All of the samples from January were negative. The earliest sample that tested positive was February 20.
Based on that and later case counts, Trevor Bedford, who studies the evolution of viruses at the Fred Hutchinson Cancer Research Center in Seattle, and who was part of the flu study team, estimated that there were probably a few hundred cases in the area by that point in February.
But even that would still be a small fraction perhaps less than 1% of the many thousands of people who had flu symptoms at the time.
Q: When did the coronavirus first reach the United States?
A: The U.S. first identified cases among travelers who had flown in from Wuhan, China, in the middle of January. Officials worked to contain them.
There is some evidence that the virus began getting a bit of traction around the end of January. To seed that late-February emergence in the Seattle area, researchers believe the spread could have begun with a traveler who arrived in the region from Wuhan on Jan. 15, or it may have been another unknown case that arrived in the few weeks that followed.
In San Jose, tissue sampling from a woman who died on Feb. 6 revealed that she was probably the first known person in the U.S. whose death was linked to the coronavirus a strong sign that the virus may have been circulating in that part of Northern California in January.
Q: But was it part of a large, previously unrecognized outbreak?
A: Dr. George Rutherford, a professor of epidemiology and biostatistics at the University of California, San Francisco, theorized that perhaps the woman, who worked for a company that had an office in Wuhan, was one of only a small number of people who contracted the virus at that time and that transmissions probably petered out for some reason. Otherwise, he said, the region would have seen a much bigger outbreak.
With that kind of early introduction, we should be seeing thousands of more cases, Rutherford said.
Dr. Sara Cody, the health officer for Santa Clara County, said local, state and federal officials were continuing to try to answer those questions.
There are other, less concrete signs of earlier infections. In Florida, where the first two official cases were announced on March 1, a state database now lists coronavirus cases in patients who may have had symptoms as far back as January. But the cases are all under investigation, and no one has confirmed that any of those patients had the disease that early.
One of them is Raul Pino, the health officer for the Florida Department of Health in Orange County. He said recently that he suspects he had the virus in the first week of January.
Q: What if the virus quietly arrived in December?
A: Doctors in France have said that a patients sample from late December has since tested positive for coronavirus. But so far, there is no comparable evidence of a similar case in the United States.
The strongest possible indicator so far is new evidence that emerged this week of two people in Snohomish County, Washington, who reported coronavirus-like symptoms in December. Both people later tested positive for antibodies, county health officials announced.
But Dr. Chris Spitters, the countys health officer, said that while it is possible that both people had the coronavirus in December even before officials in China had reported a cluster to the World Health Organization at the end of the month he is doubtful.
Its possible and frankly, I think, more likely that they had a non-COVID respiratory viral illness in December and subsequently had an asymptomatic or minimally symptomatic COVID infection subsequent to that, Spitters said.
Bedford said he also believed this was the more likely scenario, noting that up to half of people with coronavirus infections have no symptoms.
There could have been a tiny number of isolated coronavirus cases among travelers to the United States in December, Bedford said. But its pretty clear that none of them spread.
In part, scientists can tell that by looking at the genomic fingerprints of each case. But another clue is the rapid rate at which the virus spreads, said Rutherford.
It appears that early in the outbreak, one infection was spreading to about four other people, on average, with an incubation period for new infections of about four days. So a case seeded in December would rapidly quadruple through new generations, likely growing exponentially to millions of cases from a single unbroken chain of transmission by the end of February. Researchers arent seeing any chains that appear to go that far back.
Modelers looking back at the growth of outbreaks elsewhere have reached similar conclusions. One estimated that New Yorks outbreak could have begun with perhaps 10 infected people who contracted the virus sometime between the end of January to the middle of February, when the first cases of community transmission were identified and hospitals began seeing more cases.
Q: When did the virus begin in China?
A: The virus first emerged in Wuhan in December after a series of people developed symptoms of a viral pneumonia and an examination found that they had been infected with a new coronavirus.A group of researchers in China later examined the histories of the first 41 lab-confirmed cases at a Wuhan hospital, finding that many of them had connections to a seafood market. But the earliest case, in a person who developed symptoms on Dec. 1, had no connections to the market.
The information suggests that if the virus did originate from the market, it was likely circulating by November, early enough to reach that first person. Bedford said it was conceivable to him that the virus began as early as October, but that November was more likely.
There is no evidence that it started elsewhere. The virus mutates an average of twice a month, something researchers can see in the genomic sequences of individual cases, and all of the cases in Wuhan show close genetic links.
All the other thousands of cases that have been sequenced around the globe show the Wuhan version as an ancestor.
Q: Was the coronavirus made in a lab somewhere?
A: Several unfounded theories that have gained traction suggest that the virus was created or accidentally released in a lab somewhere. The Chinese government speculated that perhaps Americans brought the virus in to China. President Donald Trump has suggested it came from a virology lab in Wuhan.
Bedford said there is no evidence of genetic engineering in the virus, noting that it appears to be a genetic outgrowth of a virus circulating among bats. It likely reached humans through an intermediate animal, such as a pangolin, he said.
Theres no hallmarks of it having been manipulated in a lab, Bedford said. I think thats definitive.
He did not, however, rule out the possibility that some version of the virus being studied by scientists in Wuhan could have somehow escaped and spread from there. But he doubts that is the case. He said that the most prevalent theory about the viruss origins, that it spread naturally among animals at a live animal market in Wuhan, then jumped to humans, is the most likely explanation.
Follow this link:
When did coronavirus arrive in the US? Heres a review of the evidence - Economic Times
- genetic engineering summary | Britannica - September 13th, 2024
- The great gene editing debate: can it be safe and ethical? - BBC.com - September 13th, 2024
- Anti-biotechnology campaigners embrace classic crops, are suspicious of hybrid varieties and claim genetic modification violates nature. Heres a... - September 13th, 2024
- Will IL-11 Control Extend Human Life One Day? Early Results are Tantalizing - Securities.io - September 13th, 2024
- Viewpoint: As New Zealand edges toward relaxing its ban on gene edited foods, experts weigh in - Genetic Literacy Project - September 13th, 2024
- Farmers in Brazil and Argentina ramp up growing of genetically-modified drought tolerant wheat that can grow in subtropical regions - Genetic Literacy... - September 13th, 2024
- Scientist explains why we'll never have a real Jurassic Park - and people are crestfallen - indy100 - September 13th, 2024
- Genetic engineering techniques - Wikipedia - January 9th, 2024
- 20.3: Genetic Engineering - Biology LibreTexts - January 9th, 2024
- Genetic engineering - DNA Modification, Cloning, Gene Splicing - December 13th, 2023
- Global Gene Editing Market Poised for Significant Growth, Projected to Reach $14.28 Billion by 2027 - EIN News - December 13th, 2023
- Principles of Genetic Engineering - PMC - National Center for ... - May 17th, 2023
- Quitting: A Life Strategy: The Myth of Perseveranceand How the New Science of Giving Up Can Set You Free - Next Big Idea Club Magazine - May 17th, 2023
- 18 Human Genetic Engineering - Clemson University - March 29th, 2023
- Pros and Cons of Genetic Engineering - Benefits and Risks - March 29th, 2023
- How artificial skin is made and its uses, from treating burns to skin cancer - South China Morning Post - March 29th, 2023
- Genetic Engineering - Meaning, Applications, Advantages and Challenges ... - March 13th, 2023
- Revolutionary Specialty Enzymes Transform Industries, Projected to Reach $2.2 Billion by 2031 - Billion-Dollar - EIN News - March 5th, 2023
- Explained: What is genome editing technology and how is it different from GM technology? - The Indian Express - April 2nd, 2022
- Scribe Therapeutics to Participate in Upcoming Goldman Sachs The New Guard: Privates Leading the Disruption in Healthcare Investor Conference - Yahoo... - April 2nd, 2022
- San Antonio Zoo In Discussions on Woolly Mammoth Project - iHeart - April 2nd, 2022
- Xenotransplantation trials will require adjusting expectations, experts say - STAT - April 2nd, 2022
- 5 Interesting Startup Deals You May Have Missed In March: Restoring The Woolly Mammoth, Faux Seafood And Lots Of Bees - Crunchbase News - April 2nd, 2022
- Synlogic to Present Data on Phenylketonuria and Homocystinuria Programs at the Society for ... - KULR-TV - April 2nd, 2022
- The Bay Area food tech industry is creating more than vegan burgers. Heres whats next - San Francisco Chronicle - April 2nd, 2022
- Student Startup Teams to Compete For $110000 Cash Prize Pool in U of A's Heartland Challenge - University of Arkansas Newswire - April 2nd, 2022
- Should we test for differences in allergen content between varieties of crops and animal species? - Open Access Government - April 2nd, 2022
- Genetic Engineering - Courses, Subjects, Eligibility ... - December 22nd, 2021
- Scientists Used CRISPR Gene Editing to Choose the Sex of Mouse Pups - Singularity Hub - December 22nd, 2021
- Report calls for broad public deliberation on releasing gene-edited species in the wild - EurekAlert - December 22nd, 2021
- RNA and DNA Extraction Kit Market Study | Know the Post-Pandemic Scenario of the Industry - BioSpace - December 22nd, 2021
- Opinion: Allow Golden Rice to save lives - pnas.org - December 22nd, 2021
- It's time for an alliance of democracies | TheHill - The Hill - December 22nd, 2021
- Aridis Pharmaceuticals Announces a Pan-Coronavirus Monoclonal Antibody Cocktail That Retains Effectiveness Against the Omicron variant, other COVID-19... - December 22nd, 2021
- 2021: when the link between the climate and biodiversity crises became clear - The Guardian - December 22nd, 2021
- Wuhan lab leak now the most likely cause of Covid pandemic and the truth WILL come out, experts tell MPs... - The US Sun - December 22nd, 2021
- Biotech ETFs That Outperformed Last Week - Yahoo Finance - December 22nd, 2021
- Human genetic enhancement - Wikipedia - October 5th, 2021
- Viewpoint: Part 1 Opposition stirred by anti-GMO advocacy group propaganda fading in the developing world, as more countries embrace crop... - October 5th, 2021
- Amyris Partners with Inscripta to Enhance Development of Sustainable Ingredients Using the Onyx Genome Engineering Platform - WWNY - October 5th, 2021
- Kingdom Supercultures raises $25m to expand Non GMO suite of microbes to unlock new flavors, textures, and functionalities in food & beverage -... - October 5th, 2021
- Fact check: Genetically engineering your salad with the COVID-19 vaccines? We're not there yet. - USA TODAY - October 5th, 2021
- Making the Transition from an Academic to a Biobusiness Entrepreneur - Genetic Engineering & Biotechnology News - October 5th, 2021
- Is The New York Times Finally 'Learning To Love GMOS'? - American Council on Science and Health - October 5th, 2021
- Gene editing, joke theft and manifesting - The Week UK - October 5th, 2021
- Opinion: Saving lives through real social justice - Agri-Pulse - October 5th, 2021
- Science, business and the humanities: CP Snow's 'Two Cultures' sixty years on - TheArticle - October 5th, 2021
- Probiotic Yeast Engineered To Produce Beta-Carotene - Technology Networks - April 17th, 2021
- In the US, Imminent Release of Genetically Modified Mosquitoes To Fight Dengue - The Wire Science - April 17th, 2021
- CRISPRoff: A New Addition to the CRISPR Toolbox - Technology Networks - April 17th, 2021
- A Massive New Gene Editing Project Is Out to Crush Alzheimer's - Singularity Hub - April 17th, 2021
- Grammar of the Genome: Reading the Influence of DNA on Disease - Baylor University - April 17th, 2021
- We cannot let China set the standards for 21st century technologies | TheHill - The Hill - April 17th, 2021
- First GMO Mosquitoes to Be Released in the Florida Keys - Singularity Hub - April 17th, 2021
- Novavax to Participate in University of Oxford Com-COV2 Study Comparing Mixed COVID-19 Vaccine Combinations - BioSpace - April 17th, 2021
- AmunBio and NorthShore University to Advance Cancer Immunotherapy with Engineered Oncolytic Viruses - OncoZine - April 17th, 2021
- StrideBio Announces a Multi-technology License and Master SRA with Duke University to Advance Next-generation Gene Therapies - BioSpace - April 17th, 2021
- ThermoGenesis : The History of Cell and Gene Therapy - marketscreener.com - April 17th, 2021
- EU's refusal to permit GMO crops led to millions of tonnes of additional CO2, scientists reveal - Alliance for Science - Alliance for Science - February 14th, 2021
- New species of fly named after Singanallur Tank - The Hindu - February 14th, 2021
- Son of Monarchs Pays Homage to the Beauty of Migration - Sierra Magazine - February 14th, 2021
- Podcast: TIME's 2020 Kid of the Year, Gitanjali Rao - All Together - Society of Women Engineers - February 14th, 2021
- Geoengineering: What could possibly go wrong? Elizabeth Kolbert's take, in her new book - Bulletin of the Atomic Scientists - February 14th, 2021
- An Introduction to PCR - Technology Networks - February 14th, 2021
- Science Talk - Evolution, cancer and coronavirus how biology's 'Theory of Everything' is key to fighting cancer and global pandemics - The Institute... - February 14th, 2021
- 22nd Century Group and KeyGene Launch Advanced Cannabis Technology Platform for Accelerated Development of New Varieties of Hemp/Cannabis Plants with... - February 14th, 2021
- Aleph Farms and The Technion Reveal World's First Cultivated Ribeye Steak - PRNewswire - February 9th, 2021
- Researchers create rice that captures more CO2 with 30 percent more yield - FoodIngredientsFirst - February 9th, 2021
- Interview: Elizabeth Kolbert on why well never stop messing with nature - Grist - February 9th, 2021
- Is Biotechnology the Answer to a More Sustainable Beauty Industry? - Fashionista - February 9th, 2021
- New Jersey arts and entertainment news, features, and event previews. - New Jersey Stage - February 9th, 2021
- CollPlant Announces Development and Global Commercialization Agreement with Allergan Aesthetics, an AbbVie company, for rhCollagen in Dermal and Soft... - February 9th, 2021
- Taysha Gene Therapies Announces Collaborations to Advance Next-Generation Mini-Gene Payloads for AAV Gene Therapies for the Treatment of Genetic... - February 9th, 2021
- A new tool to investigate bacteria behind hospital infections - MIT News - February 9th, 2021
- Outlook on the CRISPR Gene Editing Global Market to 2030 - Analysis and Forecasts - GlobeNewswire - February 9th, 2021
- Novavax Announces Start of Rolling Review by Multiple Regulatory Authorities for COVID-19 Vaccine Authorization - GlobeNewswire - February 9th, 2021
- Global Lab-On-A-Chip Market Industry Perspective, Comprehensive Analysis, and Forecast 2027||Players-Perkin Elmer Corporation, IDEX, Thermo Fisher... - February 9th, 2021
- Freeline Presents Data on its Gaucher Disease and Fabry Disease AAV-Based Gene Therapies at the 17th Annual WORLDSymposium - PharmiWeb.com - February 9th, 2021
- Global Bacterial and Plasmid Vectors Market Report 2020: Market is Expected to Recover and Reach $0520 Million in 2023 at a CAGR of 15.48% - Forecast... - January 12th, 2021
- mRNA Technology Gave Us the First COVID-19 Vaccines. It Could Also Upend the Drug Industry - TIME - January 12th, 2021